Gloo Executive Director Steve Millette joins the BHE Podcast to discuss his organization’s partnership with the Psychiatry & Behavioral Health Learning Network to create the Collaborative Advancement of Recovery Excellence, a recovery research-…
The Substance Abuse and Mental Health Services Administration this week announced the adoption of 42 CFR Part 2 revisions that it says are designed to facilitate care coordination between providers while maintaining privacy protections.
Concerns over patient isolation, staff safety and licensing reciprocity between states as a means to address a shortage of care providers during a crisis were among the COVID-19-related topics discussed by a panel of industry leaders during a Friday morning session at the virtual National Conference on Addiction Disorders.
Gloo and the Psychiatry and Behavioral Health Learning Network have announced a partnership to create a virtual center of excellence aimed at improving patient outcomes among mental health treatment and addiction recovery providers.
Eight medical device makers, including a startup that uses virtual reality to treat chronic pain, topped an innovation contest aimed at addressing the opioid crisis, the U.S. Food and Drug Administration said last week.